Total Reports
16
FDA CVM filings
Dog /
FDA CVM · 2025 release 16 reports on file
Pointing Dog - French (unspecified) - FDA Adverse Event Profile
Adverse-event records for Pointing Dog - French (unspecified) (Dog) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
Pointing Dog - French (unspecified)'s FDA record: #391 most-reported dog breed, 16 total reports, 0.0% death-coded (0 reports).
- #391
- most-reported dog breed
- 0.0%
- death-coded report share
- 2
- Injection site swelling - top reaction
- 3.2 yr
- average age at report
Read report counts next to breed popularity: a bigger number often just means more owners and more vet visits.
Deaths Reported
0
of 16 reports
Death Rate
0.0%
death-coded share
Avg Age at Report
3.2 yr
22.3 kg avg weight
Death-Coded Outcome Share
Pointing Dog - French (unspecified) death-coded reports 0.0%
Cross-breed median
0.0% of 16 pointing dog - french (unspecified) reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 22.3 kg (49.2 lbs)
Top Reported Reactions
Injection site swelling 2
Lethargy (see also Central nervous system depression in 'Neurological') 2
Weight loss 2
Lack of efficacy (ectoparasite) - tick NOS 2
INEFFECTIVE, HOOKS 2
Most Referenced Drugs
Milbemycin Oxime + Spinosad 5
Ivermectin + Pyrantel As Pamoate Salt 4
Carprofen 3
Fluralaner Chew Tablets 2
Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31 1
Outcome Breakdown
Outcome Unknown
7 (43.8%)
Ongoing
5 (31.3%)
Recovered/Normal
3 (18.8%)
Recovered with Sequela
1 (6.3%)
Gender Distribution
Male 12 (75.0%)
Female 4 (25.0%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2013 | 2 | |
| 2014 | 1 | |
| 2015 | 3 | |
| 2016 | 1 | |
| 2017 | 1 | |
| 2018 | 2 | |
| 2019 | 2 | |
| 2020 | 3 | |
| 2024 | 1 | |
Pointing Dog - French (unspecified) Pet Health Insights
Pointing Dog - French (unspecified) accounts for 16 FDA adverse event reports, ranking #391 by volume among dog breeds, with 0 reports (0.0%) coded as a death outcome. Mean age at report: 3.2 years, average weight 22.3 kg (49.2 lbs).
Top reported signs: Injection site swelling (2), Lethargy (see also Central nervous system depression in 'Neurological') (2), Weight loss (2). Most-referenced drug: Milbemycin Oxime + Spinosad (5 reports), followed by Ivermectin + Pyrantel As Pamoate Salt (4) and Carprofen (3).
Outcome coding on 16 status-recorded reports is dominated by Outcome Unknown (43.8%). Annual submissions ranged 2,013-2,024 across 9 years on file.
Dog Breeds With a Similar Report Volume
Frequently Asked Questions
How many FDA adverse event reports involve Pointing Dog - French (unspecified)? ▼
There are 16 adverse event reports involving Pointing Dog - French (unspecified) in the FDA database, with 0 reports involving death (0.0% death rate). Pointing Dog - French (unspecified) ranks #391 by report volume.
What are the most common adverse reactions reported for Pointing Dog - French (unspecified)? ▼
The most commonly reported adverse reactions for Pointing Dog - French (unspecified) are Injection site swelling (2 reports), Lethargy (see also Central nervous system depression in 'Neurological') (2 reports), Weight loss (2 reports), Lack of efficacy (ectoparasite) - tick NOS (2 reports), INEFFECTIVE, HOOKS (2 reports).
What drugs are most frequently associated with Pointing Dog - French (unspecified) adverse events? ▼
The drugs most frequently referenced in Pointing Dog - French (unspecified) adverse event reports are Milbemycin Oxime + Spinosad (5 reports), Ivermectin + Pyrantel As Pamoate Salt (4 reports), Carprofen (3 reports), Fluralaner Chew Tablets (2 reports), Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31 (1 reports).
What is the average age of Pointing Dog - French (unspecified) in adverse event reports? ▼
The average age of Pointing Dog - French (unspecified) at the time of adverse event reports is 3.2 years, with an average weight of 22.3 kg (49.2 lbs).
Does a high number of adverse event reports mean Pointing Dog - French (unspecified) is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Pointing Dog - French (unspecified) safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.